What does CUSIP 02155X106 represent in this 13F holders report?

CUSIP 02155X106 is the security identifier for ATHE - ALTERITY THERAPEUTICS LTD - SPONSORED ADR used to aggregate holder disclosures.

How many institutions held ATHE - ALTERITY THERAPEUTICS LTD - SPONSORED ADR in Q4 2021?

8 institutional investors reported ATHE - ALTERITY THERAPEUTICS LTD - SPONSORED ADR for Q4 2021. Use the holders table for investor-level position and value details.

ALTERITY THERAPEUTICS LTD - SPONSORED ADR (ATHE)

CUSIP: 02155X106

Q4 2021 13F Holders as of 31 Dec 2021

Security type / class: Equity / SPONSORED ADR
Total 13F shares: 751,929
Total 13F value: $541,000
Share change: +114,115
SEC-reported price per share: $0.72
Number of holders: 8
Value change: +$62,357
Number of buys: 4
Number of sells: 8

Security key

02155X106

Report period

Q4 2021

Institutions

Top holders

ATHE full security history Ownership snapshot Full 13F holder table ALTERITY THERAPEUTICS LTD SEC filings ALTERITY THERAPEUTICS LTD company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of ATHE - ALTERITY THERAPEUTICS LTD - SPONSORED ADR (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

MORGAN STANLEY

Disclosed value leader

MORGAN STANLEY

Comparable rows

0/11

Latest evidence

30 Sep 2021

13F Highest disclosed value: $723,000 11 rows are not safely comparable across share classes. Showing 1-6 of 11 holder rows.

Quick read

MORGAN STANLEY has the largest disclosed position value at $723K.

0 of 11 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens MORGAN STANLEY's linked filing trail.

Disclosed position value Top 5

MORGAN STANLEY $723K

TWO SIGMA SECURITIES, LLC $20K

GEODE CAPITAL MANAGEMENT, LLC $15K

CITADEL ADVISORS LLC $15K

Virtu Financial LLC $14K

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 11 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
MORGAN STANLEY	13F Company 13F	— denominator unverified	$723,000 568,964 shares	—	30 Sep 2021
TWO SIGMA SECURITIES, LLC	13F Company 13F	— denominator unverified	$20,000 16,107 shares	—	30 Sep 2021
GEODE CAPITAL MANAGEMENT, LLC	13F Company 13F	— denominator unverified	$15,000 12,128 shares	—	30 Sep 2021
CITADEL ADVISORS LLC	13F Company 13F	— denominator unverified	$15,000 11,761 shares	—	30 Sep 2021
Virtu Financial LLC	13F Company 13F	— denominator unverified	$14,000 11,351 shares	—	30 Sep 2021
HRT FINANCIAL LP	13F Company 13F	— denominator unverified	$13,000 10,610 shares	—	30 Sep 2021

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2021

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

751,929

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2021 vs Q3 2021 Across Filers

Q3 2021 holders

Q4 2021 holders

Holder diff

-3

Investor	Q3 2021 Shares	Q4 2021 Shares	Share Diff	Share Chg %	Q3 2021 value	Q4 2021 value	Value change	Value Chg %